3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
21
Lymphoma, Mantle-Cell
13
Lymphoma, Non-Hodgkin
10
Lymphoma, Large B-Cell, Diffuse
10
Waldenstrom Macroglobulinemia
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma
5
Neoplasms
4
Leukemia, B-Cell
4
Lymphoma, B-Cell
3
Burkitt Lymphoma
3
Recurrence
2
Leukemia, Prolymphocytic
2
Leukemia, Lymphoid
2
Leukemia, Hairy Cell
2
Leukemia
2
Hematologic Diseases
2
Bronchiolitis Obliterans Syndrome
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Central Nervous System Lymphoma (PCNSL)
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphoma, AIDS-Related
1
Lymphatic Diseases
1
Leukemia, Prolymphocytic, B-Cell
1
Interventions
fludarabine phosphate
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclophosphamide
3
Tacrolimus
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Busulfan
2
fludarabine
1
Transplantation
1
Radiotherapy
1
Methotrexate
1
Health Promotion
1
Etoposide
1
Educational Status
1
Cyclosporine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
ibrutinib
×
90 days
×
Clear all
No trials found.